Airway Management Devices Market: Growth, Size, Share, and Trends

Market Growth Outlook Summary

The global airway management devices market, valued at US$1.8 billion in 2022, is forecasted to grow at a robust CAGR of 5.6%, reaching US$1.9 billion in 2023 and an impressive US$2.4 billion by 2028. The growth in this market is attributed to the increasing demand for airway management devices in developing countries, the rise in surgical procedures, and the growing prevalence of chronic respiratory diseases such as asthma and COPD. However, the lack of reimbursement policies in emerging countries may challenge market growth. Conversely, the increasing demand for intensive care units presents growth opportunities for the market.

Attractive Opportunities in the Airway Management Devices Market

To know about the assumptions considered for the study, Request for Free Sample Report

Airway Management Devices Market Dynamics

DRIVER: Rising incidence of pre-term births globally

Preterm birth is when a baby is born too early, before 37 weeks of pregnancy have been completed. Globally, there has been a rise in the number of premature births in recent years. Babies with breathing issues may need a mechanical ventilator to help them in breathing. These babies may also develop irregular breathing, apnea, asthma, and other respiratory diseases. Considering these points, the high and rising incidence of pre-term births drives the global demand for airway management devices. To meet the demand of different sizes and shapes of airway management products, vendors are offering products according to infants and pediatric patients’ requirements.

Restraint: Lack of reimbursement policies across emerging countries

Emerging countries have low adoption for expensive airway management devices, due to ineffective reimbursement policies or lack of public health insurance coverage. Such ineffective policies, people need to spend out of pockets which hampers the financial condition of the poor across developing countries, with a lack of support for universal health coverage. Such situations have made countries vulnerable to the risk of chronic diseases. Owing to the high out-of-pocket costs of healthcare, the adoption of expensive medical devices such as video laryngoscopes and advanced surgical procedures is low across emerging countries, that has become a key restraint in the market.

OPPORTUNITY: Rising growth potential in developing countries

Developing countries such as China, India, and Brazil are expected to provide potential growth opportunities to players operating in the market. This is primarily attributed to the large target patient population in India and China. China’s one-child policy has significantly reduced the working-age population in the country and resulted in significant growth in its old age population. Moreover, countries such as India and Malaysia have become medical tourism hubs. The cost of surgical procedures across these developing countries is far less than in developed countries such as the US, Germany, France, and the UK. The resultant rise in surgeries will contribute to the demand for anesthesia procedures and airway management.

CHALLENGE: Dearth of skilled professionals

Airway management procedures such as tracheostomy, endotracheal intubation, and cricothyrotomy procedures require highly skilled anesthetists and trained nurses. The lack of knowledge regarding the right choice of immediate treatment can adversely affect the patient’s condition, can increase the recovery time, and can surge the direct and indirect expenses. Shortage of anesthetists and paramedics has become one of the key concerns for countries across the globe. The shortage has directly impacted the efficiency and capabilities of healthcare settings to provide surgical and emergency care, further hindering the demand for airway management devices used across these procedures.

Airway Management Devices Ecosystem

Prominent companies in this market include well-established, financially stable manufacturers of airway management devices. These companies have been operating in the market for several years and possess a diversified product portfolio, state-of-the-art technologies, and strong global sales and marketing networks. Prominent companies in this market include Medtronic (Ireland), ICU Medical, Inc. (US), Teleflex Incorporated (US), Ambu A/S (Denmark), ConvaTec Group Plc (UK

In 2022, infraglottic segment to observe highest growth rate of the airway management devices market, by type

Based on the type, the infraglottic segment is expected to observe highest growth during the forecast period. Factors attributing high growth is due to rise in prevalence of cardiovascular diseases, chronic respiratory diseases, and respiratory tract infections are increasing the incidence of acute respiratory failure, thereby driving the demand of intubation procedures and infraglottic devices globally.

In 2022, anesthesia segment is expected to account for the largest share of the airway management devices market, by application.

By application, the anesthesia segment accounted for the largest share during the forecast period. Factors attributing to the large segment of this market include the rising number of surgical interventions. Moreover, the growing need for maintaining a safe breathing passage to lower the risk of anesthesia-related complications during surgery is also driving the use of airway management devices during anesthesia procedures.

The pediatric patient segment of airway management devices market is expected to grow at the highest rate during the forecast period.

The pediatric/neonatal patients segment is expected to grow at the highest CAGR in the market during the forecast period. The rising number of pre-term births globally are driving a rapid demand for airway management across pediatric/neonatal patients.

In 2022, Hospitals segment accounted for the largest share of the airway management devices market, by end user.

The hospital segment accounted for the largest market share during the forecast period. The high share of this segment can be attributed to the increasing number of hospitals and infrastructural & economic development, especially in developing countries. Moreover, the increasing surgical procedure during any surgery also supports high growth in the hospitals segment.

In 2022, North America to dominate in airway management devices market

The global market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America is expected to dominate during the forecast period, primarily due to presence of highly developed healthcare system, the increasing prevalence of chronic respiratory diseases, and favorable reimbursement policies for airway management devices.

To know about the assumptions considered for the study, download the pdf brochure

The airway management devices market is dominated by players such Medtronic (Ireland), ICU Medical, Inc. (US), Teleflex Incorporated (US), Ambu A/S (Denmark), ConvaTec Group Plc (UK).

Airway Management Devices Market Report Scope

This research report categorizes the airway management devices market to forecast revenue and analyze trends in each of the following submarkets:

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

By Product

• Imfraglottic Devices
• Supraglottic Devices
• Laryngoscopes
• Resuscitators
• Cricothyrotomy kits
• Other Airway Management Devices

By Patient Age

• Adult Patients
• Pediatric Patients/Neonates

By Application

• Anesthesia
• Emergency Medicine
• Other applications

By End User

• Hospitals
• Ambulatory care settings
• Home care settings
• Others

Recent Developments

• In 2022, SunMed Holdings (US) announced a strategic partnership with Securisyn Medical LLC (US) to enhance ventilated patient safety and broader smooth tube and catheter security.
• In 2022, Coloplast A/S acquired Atos Medical to add a new chronic business segment – ENT & Respiratory Care, which will run as a separate strategic unit, operating on shared Coloplast infrastructure.
• In 2022, ICU Medical, Inc. acquired Smiths Medical (US), which includes a syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical’s existing businesses, it created a leading infusion therapy company.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst